Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers

Cancer treatment is constantly evolving from a one-size-fits-all towards bespoke approaches for each patient. In certain solid cancers, including breast and lung, tumor genome profiling has been incorporated into therapeutic decision-making. For chronic phase chronic myeloid leukemia (CML), while ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Vaidehi, Kim, Dennis Dong Hwan, Hughes, Timothy P., Branford, Susan, Ong, S. Tiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804571/
https://www.ncbi.nlm.nih.gov/pubmed/34615339
http://dx.doi.org/10.3324/haematol.2021.279317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804571/
https://www.ncbi.nlm.nih.gov/pubmed/34615339
http://dx.doi.org/10.3324/haematol.2021.279317

Ejemplares similares